BioSpace News Archive

CStone Pharmaceuticals is pleased to announce the appointment of three internationally renowned oncologists Paul A. Bunn, Jr., MD, Elizabeth M. Jaffee, MD, and Richard S. Finn, MD, as the company’s Scientific Advisory Board (SAB) members.

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.

Diamond Pharma Services has provided EU regulatory support to Akcea since 2016, resulting in a positive CHMP opinion for the grant of a Conditional Marketing Authorisation for WAYLIVRA

Fuse Medical, Inc., (OTCPINK: FZMD), an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has won ‘Small Business of the Year’ category at the Cambridge News Business Excellence Awards 2019.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced the appointment of David Ellis, Ph.D., as Director, Chemistry, reporting to Mitchell deLong, Ph.D., Aerie’s Vice President of Chemistry.

Global digital therapeutics innovator DarioHealth Corp. (Nasdaq: DRIO), today reported record financial and operational results for the full-year ended on December 31, 2018.

imaware™, the at-home testing platform for chronic illness and disease, designed by healthcare company Microdrop, today announced a study utilizing its platform has been peer reviewed by one of the world’s top clinical chemistry journals, Clinical Chemistry and Laboratory Medicine (CCLM)

In honor of children fighting cancer, for the 4th year in a row, The National Pediatric Cancer Foundation (NPCF) has partnered with global surplus surgical supply company, WestCMR, and CEO and Founder, Randy Ware, to co-host a Cut for a Cure Event at WestCMR headquarters, 11:00am-3:00pm, March 29, 2019.

Prometic Life Sciences Inc. announced that it has secured an additional USD $5 million tranche from Structured Alpha LP, an affiliate of Thomvest Asset Management Inc., under the existing loan agreement originally entered into with SALP in November 2017.